◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs
5sources
5articles
3velocity
+0%since first seen
21d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (5)
- SCTX IPO News - Cardiovascular diseases biotech Scribe Therapeutics files for a $75 million IPO renaissancecapital.com · 22d ago
- Meet the gene-editing, cholesterol-fighting Alameda company looking for IPO riches The Business Journals · 22d ago
- Scribe Therapeutics files for proposed Nasdaq IPO By Investing.com Investing.com South Africa · 22d ago
- Scribe Therapeutics Stockholders Include Eli Lilly Moomoo · 22d ago
- Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs Endpoints News · 22d ago
Related trends
▲ Peaking
Business
FDA recalls 180,000 cans of soup sold at Walmart - the-sun.com
Amy's Kitchen has issued a voluntary recall for over 184,000 cans of lentil soup following reports of a potential product defect.
▲ Peaking
Business
Palantir Estimates Rise as Citi Sees Commercial Growth Rebound
Palantir shares fluctuate as market analysts adjust growth estimates ahead of scheduled earnings reports.
▲ Peaking
Business
New Jersey becomes one of the first states to ban dynamic pricing
▲ Peaking
Business
Nvidia locks down memory supply from SK Hynix as part of $500 billion AI deal
▲ Peaking
Business
AI executives demand OpenAI release more details about how the Hugging Face hack happened
▲ Peaking
Business